Table of Contents
What changed
Total income jumped to NZ$40.3m from NZ$10.7m, a 276.5% increase that reflects a swing back to positive capital returns after a loss-making comparable period. Despite this, profit before tax moved only marginally higher at NZ$33.2m (+3.0%), and NPAT actually fell 4.5% to NZ$29.7m. The gap between PBT and NPAT growth is 7.5pp, driven entirely by the effective tax rate rising from 3.5% to 10.5%.
Cash and leverage both strengthened. Operating cash outflow narrowed to NZ$5.0m from NZ$12.6m, cash rose to NZ$13.7m from NZ$7.0m, and gross borrowings fell to NZ$25.5m from NZ$30.1m, taking net debt to NZ$11.8m from NZ$23.1m. The declared full-year dividend was 23.40p, up 1.7% on 23.00p.
What matters
- PBT is the cleaner read this period. PBT grew 3.0% while NPAT fell 4.5% solely because of a step-up in the effective tax rate. The underlying earnings direction is slightly positive, not negative.
- Revenue comparability is distorted. Total income for this vehicle blends investment income with capital gains/losses on the portfolio. The NZ$29.6m uplift in revenue and the FY21 full-year loss of NZ$48.8m both reflect portfolio mark-to-market swings rather than an operating trend that compounds.
- Payout ratio remains above 100%. The 23.40p dividend implies a payout ratio of 114.7% of NPAT (up from 105.5%), so the distribution continues to be funded partly from reserves rather than earnings alone.
Expectations
No quantified targets or forward-work disclosures were provided. The only shape context is FY21, where HY21 accounted for 30.3% of full-year revenue and −63.7% of full-year NPAT — a pattern distorted by a large second-half capital loss (implied H2 NPAT of −NZ$79.9m). Annualised HY22 revenue of NZ$80.7m sits well above the FY21 total of NZ$35.3m, but because this figure is dominated by portfolio capital movements, the annualisation should not be read as a run-rate. The release does support a clearly improved capital-return environment versus FY21; it does not support a claim about sustainable income growth.
Quality of result
Quality is mixed. The income component looks durable enough to fund a modestly growing dividend (PBT +3.0%, dividend +1.7%), but the headline revenue and NPAT moves are dominated by unrealised capital returns that can reverse. The improvement in operating cash (still an outflow of NZ$5.0m) and the reduction in gross borrowings are real and balance-sheet-supportive. However, the dividend remains uncovered by NPAT at a 114.7% payout ratio, and ROE edged down to 6.6% from 6.9%, so the return generated on the enlarged equity base is not improving despite the revenue rebound.
Unresolved
- What drove the effective tax rate from 3.5% to 10.5%, and is the higher rate structural?
- How much of the NZ$40.3m total income is recurring investment income versus non-recurring capital gains?
- Is the board prepared to continue funding above-100% payout ratios from reserves, and for how long?
- No disclosure was provided on portfolio concentration, forward income visibility, or quantified FX exposure beyond a NZ$0.5m translation movement.
This briefing cannot assess NAV per share, discount/premium to NAV, or total shareholder return against the benchmark indices referenced in the release, because those figures were not supplied in the extraction.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $40.3m | $10.7m | +276.5% ↑ |
| Net profit after tax | $29.7m | $31.1m | -4.5% ↓ |
| Net cash inflow from operating activities | −$5.0m | −$12.6m | +60.2% ↑ |
| Cash and cash equivalents | $13.7m | $7.0m | +96.3% ↑ |
| Total assets | $481.6m | $491.4m | -2.0% ↓ |
Reference: annolyse.ai/briefings/hfl-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | +3.0% | — | cleaner earnings measure |
| Effective tax rate | 10.5% | 3.5% | — |
| Net debt | $11.8m | $23.1m | −$11.3m |
| Gross borrowings | $25.5m | $30.1m | −$4.6m |
| Payout ratio vs NPAT | 114.7% | — | — |
| ROE (annualised) | 6.6% | 6.9% | Weakening |
| HY21 share of FY21 revenue | 30.3% | — | Other half was 69.7% |
| HY21 share of FY21 NPAT | -63.7% | — | Other half was 163.7% |
| Profit from continuing operations | $29.7m | $31.1m | −$1.4m |
Reference: annolyse.ai/briefings/hfl-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.